The molecular diagnostic test detects Shiga toxin-producing E. coli and the serotype O157 directly from a patient specimen.
A recent study determined a particular geneset was the best method to normalize RT-qPCR data from a specific model system, with caveats.
The Australian firm provided an update on its in vitro diagnostics business, noting that it has also rebranded its core technologies and continues to license them.
The firm will use the award to develop silica nanomaterial for use with many sample types, including blood, cultured cells, and pathogens.
A majority of respondents said liquid biopsy is poised to become a widely used tool for assessing cancer mutations within the next one to four years, with NGS-based analysis preferred over other testing modalities.
In Nature this week: genomic analysis of 200 bird species, and more.
The Australian High Court rules that isolated genetic material cannot be patented.
The startup incubator Y Combinator is launching a nonprofit research lab.
In Genome Research this week: vervet genome, tandem repeats affect gene expression in great apes, and more.